Home / Latest Reports / Over The Counter Otc Drugs Market

Over-the-counter (OTC) Drugs Market By Product - Global Industry Analysis And Forecast To 2027

Published On : February 2019 Pages : 160 Category: Pharmaceuticals Report Code : HC022705

SEGMENTS & REGIONS:

  • Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa

Over-the-counter (OTC) Drugs Market By Product (Ophthalmic Products, Analgesics, Sleeping Aids, Cold, Cough & Flu Products, Mineral & Vitamin Supplements, Weight Loss Products, Skin Products, Gastrointestinal Products and Other Products) - Global Industry Analysis And Forecast To 2027

Industry Outlook

The Over-the-counter (OTC) drugs are the medications sold specifically to the consumers without the medicinal services professional prescription, rather than the physician recommended medications, which might be sold just to the customers having the substantial prescription. In numerous nations, the OTC medications are chosen by the administrative office to guarantee that they have the ingredients which are effective and safe when utilized without the doctor's consideration. Therefore, the Over-the-counter (OTC) Drugs Market is anticipated to expand and has tremendous scope during the forecast period. The global Over-the-counter (OTC) Drugs Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

By Product the market is segmented into Ophthalmic Products, Analgesics, Sleeping Aids, Cold, Cough & Flu Products, Mineral & Vitamin Supplements, Weight Loss Products, Skin Products, Gastrointestinal Products and Other Products. The Mineral & Vitamin Supplements sections accounts over quarter of the market share globally due to increasing utilization of these products and some other factors.

Regional Insights

The economies like Japan, US & China lead the market with about half of the market share due to more saturation of various types of products, faster technological development in economies and other factors.

Over-the-counter (OTC) Drugs Market, By Region

    • North America
  • U.S.
  • Canada
  • Mexico
    • Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
    • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
      • South America
  • Brazil
  • Argentina
  • Columbia
  • Rest of South America
    • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of MEA

Competitive Analysis

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

  • Cipla
  • Bayer
  • Dr. Reddy’s Laboratories
  • Sanofi
  • Takeda
  • Pfizer
  • GloxoSmithKline
  • Johnson & Johnson

Some of the key questions answered by the report are:          

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

o   Over-the-counter (OTC) Drugs Market, By Product, Estimates and Forecast, 2017-2027 ($Million)

o   Ophthalmic Products

o   Analgesics

o   Sleeping Aids

o   Cold, Cough & Flu Products

o   Mineral & Vitamin Supplements

o   Weight Loss Products

o   Skin Products

o   Gastrointestinal Products

o   Other Products

o   Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o   North America

§  North America Over-the-counter (OTC) Drugs Market, By Country

o   U.S. Over-the-counter (OTC) Drugs Market

o   Canada Over-the-counter (OTC) Drugs Market

o   Mexico Over-the-counter (OTC) Drugs Market

o   Europe

§  Europe Over-the-counter (OTC) Drugs Market, By Country

o   Germany Over-the-counter (OTC) Drugs Market

o   UK Over-the-counter (OTC) Drugs Market

o   France Over-the-counter (OTC) Drugs Market

o   Russia Over-the-counter (OTC) Drugs Market

o   Italy Over-the-counter (OTC) Drugs Market

o   Rest of Europe Over-the-counter (OTC) Drugs Market

o   Asia-Pacific

§  Asia-Pacific Over-the-counter (OTC) Drugs Market, By Country

o   China Over-the-counter (OTC) Drugs Market

o   Japan Over-the-counter (OTC) Drugs Market

o   South Korea  Over-the-counter (OTC) Drugs Market

o   India Over-the-counter (OTC) Drugs Market

o   Southeast Asia Over-the-counter (OTC) Drugs Market

o   Rest of Asia-Pacific Over-the-counter (OTC) Drugs Market

o   South America

§  South America Over-the-counter (OTC) Drugs Market, By Country

o   Brazil Over-the-counter (OTC) Drugs Market

o   Argentina Over-the-counter (OTC) Drugs Market

o   Columbia Over-the-counter (OTC) Drugs Market

o   Rest of South America Over-the-counter (OTC) Drugs Market

o   Middle East and Africa

§  Middle East and Africa Over-the-counter (OTC) Drugs Market, By Country

o   Saudi Arabia Over-the-counter (OTC) Drugs Market

o   UAE Over-the-counter (OTC) Drugs Market

o   Egypt Over-the-counter (OTC) Drugs Market

o   Nigeria Over-the-counter (OTC) Drugs Market

o   South Africa Over-the-counter (OTC) Drugs Market

o   Rest of MEA Over-the-counter (OTC) Drugs Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Over-the-counter (OTC) Drugs Market, By Product

5.1.     Introduction

5.2.     Global Over-the-counter (OTC) Drugs Revenue and Market Share by Product (2017-2027)

5.2.1.  Global Over-the-counter (OTC) Drugs Revenue and Revenue Share by Product (2017-2027)

5.3.     Ophthalmic Products

5.3.1.  Global Ophthalmic Products Revenue and Growth Rate (2017-2027)

5.4.     Analgesics

5.4.1.  Global Analgesics Revenue and Growth Rate (2017-2027)

5.5.     Sleeping Aids

5.5.1.  Global Sleeping Aids Revenue and Growth Rate (2017-2027)

5.6.     Cold, Cough & Flu Products

5.6.1.  Global Cold, Cough & Flu Products Revenue and Growth Rate (2017-2027)

5.7.     Mineral & Vitamin Supplements

5.7.1.  Global Mineral & Vitamin Supplements Revenue and Growth Rate (2017-2027)

5.8.     Weight Loss Products

5.8.1.  Global Weight Loss Products Revenue and Growth Rate (2017-2027)

5.9.     Skin Products

5.9.1.  Global Skin Products Revenue and Growth Rate (2017-2027)

5.10. Gastrointestinal Products

5.10.1.      Global Gastrointestinal Products Revenue and Growth Rate (2017-2027)

5.11. Other Products

5.11.1.      Global Other Products  Revenue and Growth Rate (2017-2027)

6.       Over-the-counter (OTC) Drugs Market, By Region

6.1.     Introduction

6.2.     Global Over-the-counter (OTC) Drugs Revenue and Market Share by Regions

6.2.1.  Global Over-the-counter (OTC) Drugs Revenue by Regions (2017-2027)

6.3.     North America Over-the-counter (OTC) Drugs by Countries

6.3.1.  North America Over-the-counter (OTC) Drugs Revenue and Growth Rate (2017-2027)

6.3.2.  North America Over-the-counter (OTC) Drugs Revenue (Million USD) by Countries (2017-2027)

6.3.3.  United States

6.3.3.1.  United States Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

6.3.4.  Canada

6.3.4.1.  Canada Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

6.3.5.  Mexico

6.3.5.1.  Mexico Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.     Europe Over-the-counter (OTC) Drugs by Countries

6.4.1.  Europe Over-the-counter (OTC) Drugs Revenue and Growth Rate (2017-2027)

6.4.2.  Europe Over-the-counter (OTC) Drugs Revenue (Million USD) by Countries (2017-2027)

6.4.3.  Germany

6.4.3.1.  Germany Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.4.  France

6.4.4.1.  France Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.5.  UK

6.4.5.1.  UK Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.6.  Russia

6.4.6.1.  Russia Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.7.  Italy

6.4.7.1.  Italy Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.8.  Rest of Europe

6.4.8.1.  Rest of Europe Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.     Asia-Pacific Over-the-counter (OTC) Drugs by Countries

6.5.1.  Asia-Pacific Over-the-counter (OTC) Drugs Revenue and Growth Rate (2017-2027)

6.5.2.  Asia-Pacific Over-the-counter (OTC) Drugs Revenue (Million USD) by Countries (2017-2027)

6.5.3.  China

6.5.3.1.  China Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.4.  Japan

6.5.4.1.  Japan Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.5.  Korea

6.5.5.1.  Korea Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.6.  India

6.5.6.1.  India Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.7.  Southeast Asia

6.5.7.1.  Southeast Asia Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.8.  Rest of Asia-Pacific

6.5.8.1.  Rest of Asia-Pacific Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.     South America Over-the-counter (OTC) Drugs by Countries

6.6.1.  South America Over-the-counter (OTC) Drugs Revenue and Growth Rate (2017-2027)

6.6.2.  South America Over-the-counter (OTC) Drugs Revenue (Million USD) by Countries (2017-2027)

6.6.3.  Brazil

6.6.3.1.  Brazil Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.4.  Argentina

6.6.4.1.  Argentina Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.5.  Columbia

6.6.5.1.  Columbia Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.6.  Rest of South America

6.6.6.1.  Rest of South America Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.     Middle East and Africa Over-the-counter (OTC) Drugs by Countries

6.7.1.  Middle East and Africa Over-the-counter (OTC) Drugs Revenue and Growth Rate (2017-2027)

6.7.2.  Middle East and Africa Over-the-counter (OTC) Drugs Revenue (Million USD) by Countries (2017-2027)

6.7.3.  Saudi Arabia

6.7.3.1.  Saudi Arabia Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.4.  United Arab Emirates

6.7.4.1.  United Arab Emirates Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.5.  Egypt

6.7.5.1.  Egypt Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.6.  Nigeria

6.7.6.1.  Nigeria Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.7.  South Africa

6.7.7.1.  South Africa Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.8.  Turkey

6.7.8.1.  Turkey Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.9.  Rest of Middle East and Africa

6.7.9.1.  Rest of Middle East and Africa Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

7.       Company Profiles

7.1.     Cipla

7.1.1.  Business Overview

7.1.2.   Service Portfolio

7.1.3.  Strategic Developments

7.1.4.  Financial Overview

7.2.     Bayer

7.2.1.  Business Overview

7.2.2.   Service Portfolio

7.2.3.  Strategic Developments

7.2.4.  Financial Overview

7.3.     Dr. Reddy’s Laboratories

7.3.1.  Business Overview

7.3.2.   Service Portfolio

7.3.3.  Strategic Developments

7.3.4.  Financial Overview

7.4.     Sanofi

7.4.1.  Business Overview

7.4.2.   Service Portfolio

7.4.3.  Strategic Developments

7.4.4.  Financial Overview

7.5.     Takeda

7.5.1.  Business Overview

7.5.2.   Service Portfolio

7.5.3.  Strategic Developments

7.5.4.  Financial Overview

7.6.     Pfizer

7.6.1.  Business Overview

7.6.2.   Service Portfolio

7.6.3.  Strategic Developments

7.6.4.  Financial Overview

7.7.     GloxoSmithKline

7.7.1.  Business Overview

7.7.2.   Service Portfolio

7.7.3.  Strategic Developments

7.7.4.  Financial Overview

7.8.     Johnson & Johnson

7.8.1.  Business Overview

7.8.2.   Service Portfolio

7.8.3.  Strategic Developments

7.8.4.  Financial Overview

8.       Global Over-the-counter (OTC) Drugs Market Competition, by Manufacturer

8.1.     Global Over-the-counter (OTC) Drugs Revenue and Market Share by Manufacturer (2017-2017)

8.2.     Global Over-the-counter (OTC) Drugs Price By Region (2017-2017)

8.3.     Top 5 Over-the-counter (OTC) Drugs Manufacturer Market Share

8.4.     Market Competition Trend

9.       Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.1.     Global Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2027)

9.2.     Over-the-counter (OTC) Drugs Market Forecast by Regions (2017-2027)

9.2.1.  North America Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.1.1.  United States Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.1.2.  Canada Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.1.3.  Mexico Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.2.  Europe Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.2.1.  Germany Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.2.2.  France Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.2.3.  UK Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.2.4.  Russia Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.2.5.  Italy Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.2.6.  Rest of Europe Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.3.  Asia-Pacific Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.3.1.  China Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.3.2.  Japan Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.3.3.  Korea Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.3.4.  India Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.3.5.  Southeast Asia Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.3.6.  Rest of Asia-Pacific Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.4.  South America Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.4.1.  Brazil Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.4.2.  Argentina Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.4.3.  Columbia Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.4.4.  Rest of South America Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.5.  Middle East and Africa Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.5.1.  Saudi Arabia Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.5.2.  United Arab Emirates Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.5.3.  Egypt Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.5.4.  Nigeria Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.5.5.  South Africa Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.5.6.  Turkey Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.2.5.7.  Rest of Middle East and Africa Over-the-counter (OTC) Drugs Market Forecast (2017-2027)

9.3.     Over-the-counter (OTC) Drugs Market Forecast by Product (2017-2027)

9.3.1.  Over-the-counter (OTC) Drugs Forecast by Product (2017-2027)

9.3.2.  Over-the-counter (OTC) Drugs Market Share Forecast by Product (2017-2027)

List of Tables

List of Tables and Figures:

Figure United States Over-the-counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Over-the-counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Over-the-counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Over-the-counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Over-the-counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Over-the-counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Over-the-counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Over-the-counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Over-the-counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Over-the-counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Over-the-counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Over-the-counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Over-the-counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Over-the-counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Over-the-counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Over-the-counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Over-the-counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Over-the-counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Over-the-counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Over-the-counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Over-the-counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Over-the-counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Over-the-counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Over-the-counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Over-the-counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Over-the-counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Over-the-counter (OTC) Drugs Revenue and Revenue Share by Product (2017-2018)
Figure Global Ophthalmic Products Revenue and Growth Rate (2017-2018)
Figure Global Analgesics Revenue and Growth Rate (2017-2018)
Figure Global Sleeping Aids Revenue and Growth Rate (2017-2018)
Figure Global Cold, Cough & Flu Products Revenue and Growth Rate (2017-2018)
Figure Global Mineral & Vitamin Supplements Revenue and Growth Rate (2017-2018)
Figure Global Weight Loss Products Revenue and Growth Rate (2017-2018)
Figure Global Skin Products Revenue and Growth Rate (2017-2018)
Figure Global Gastrointestinal Products Revenue and Growth Rate (2017-2018)
Figure Global Other Products Revenue and Growth Rate (2017-2018)
Table Global Over-the-counter (OTC) Drugs Revenue by Regions (2017-2018)
Figure North America Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure North America Over-the-counter (OTC) Drugs Revenue and Growth Rate (2017-2018)
Figure North America Over-the-counter (OTC) Drugs by Countries (2017-2018)
Figure North America Over-the-counter (OTC) Drugs Revenue (Million USD) by Countries (2017-2018)
Figure United States Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure United States Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure Canada Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure Mexico Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure Europe Over-the-counter (OTC) Drugs Revenue and Growth Rate (2017-2018)
Figure Europe Over-the-counter (OTC) Drugs by Countries (2017-2018)
Figure Europe Over-the-counter (OTC) Drugs Revenue (Million USD) by Countries (2017-2018)
Figure Germany Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure Germany Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure France Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure UK Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure Russia Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure Italy Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure Rest of Europe Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure Asia-Pacific Over-the-counter (OTC) Drugs Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Over-the-counter (OTC) Drugs by Countries (2017-2018)
Figure Asia-Pacific Over-the-counter (OTC) Drugs Revenue (Million USD) by Countries (2017-2018)
Figure China Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure China Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure Japan Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure Korea Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure India Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure Southeast Asia Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure South America Over-the-counter (OTC) Drugs Revenue and Growth Rate (2017-2018)
Figure South America Over-the-counter (OTC) Drugs by Countries (2017-2018)
Figure South America Over-the-counter (OTC) Drugs Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure Brazil Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure Argentina Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure Columbia Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure Rest of South America Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure Middle East and Africa Over-the-counter (OTC) Drugs Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Over-the-counter (OTC) Drugs by Countries (2017-2018)
Figure Middle East and Africa Over-the-counter (OTC) Drugs Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure Saudi Arabia Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure United Arab Emirates Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure Egypt Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure Nigeria Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure South Africa Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure Turkey Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Over-the-counter (OTC) Drugs Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Table Cipla Over-the-counter (OTC) Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Bayer Over-the-counter (OTC) Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Dr. Reddy’s Laboratories Over-the-counter (OTC) Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sanofi Over-the-counter (OTC) Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Takeda Over-the-counter (OTC) Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Pfizer Over-the-counter (OTC) Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Table GloxoSmithKline Over-the-counter (OTC) Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Johnson & Johnson Over-the-counter (OTC) Drugs Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Over-the-counter (OTC) Drugs Market Share by Manufacturer
Figure Global Over-the-counter (OTC) Drugs Revenue and Market Share by Manufacturer
Table Global Over-the-counter (OTC) Drugs Price by Region (2017-2017)
Figure Top 5 Over-the-counter (OTC) Drugs Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Over-the-counter (OTC) Drugs Revenue (Millions USD) and Growth Rate (2018-2025)
Table Over-the-counter (OTC) Drugs Market Forecast by Regions (2018-2025)
Figure North America Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure United States Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure Canada Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure Mexico Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure Europe Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure Germany Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure France Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure UK Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure Russia Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure Italy Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure Rest of Europe Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure Asia-Pacific Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure China Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure Japan Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure Korea Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure India Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure Southeast Asia Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure South America Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure Brazil Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure Argentina Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure Columbia Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure Rest of South America Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure Middle East and Africa Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure Saudi Arabia Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure United Arab Emirates Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure Egypt Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure Nigeria Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure South Africa Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure Turkey Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Over-the-counter (OTC) Drugs Market Forecast (2018-2025)
Figure Global Over-the-counter (OTC) Drugs Forecast by Product (2018-2025)
Figure Global Over-the-counter (OTC) Drugs Market Share Forecast by Product (2018-2025)
Figure Global Over-the-counter (OTC) Drugs Forecast by Product (2018-2025)

Please Note: Data related to the Companies are subject to Availability.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

Request Sample Enquire Before Buying Request for Customization

Request Sample